Press Release about Definiens:
Multi-Media Productions (USA), Inc. is pleased to announce that Definiens will be featured on 21st Century Health.
Definiens’ key customers include pathologists and radiologists at top-tier biopharmaceutical companies, leading academic research centers, and clinical service organizations. Definiens' technology is being applied in the areas of translational and clinical research in order to learn more about the underlying causes of disease, as well as make more informed “go, no-go” decisions as to whether clinical development should proceed for a possible drug candidate; saving millions of dollars in effort and time. Further, work is underway in the area of personalized medicine to apply Definiens’ technology to develop more accurate tissue and radiology-based diagnostics for accurately determining the right drug for the right patient.
Definiens has recently launched two products which are specifically geared towards efforts in personalized health care. Definiens Tissue Studio™ is an application specifically designed for pathologists engaged in translational research for tissue-based biomarkers. Definiens Tissue Studio easily, accurately, and quickly quantifies histological attributes of biopsy tissue as well as the expression levels of biomarkers. This approach unveils the underlying causes of disease which cannot be determined by traditional approaches.
Definiens LymphExpert™ assists radiologists in the identification, analysis and evaluation of lymph nodes, which are key to evaluating cancer progression. In addition to quantifying the required one- and two-dimensional RECIST and WHO criteria, Definiens Lymph Expert also enables volumetric quantification. Since tumors are three-dimensional and do not grow uniformly, volume often provides a more accurate assessment of therapeutic response or disease progression.
Definiens’ image analysis approach is also being applied by organizations seeking to leverage geospatial intelligence and earth remote sensing to better understand and quantify the natural and man-made impact on the planet. The technology ensures consistent quality, extraordinary detail, high throughput and all at significantly lower cost.
The company’s unique Definiens Cognition Network Technology is fundamentally different from conventional image analysis methods. Developed by the 1986 Physics Nobel Laureate Gerd Binnig, it emulates human cognitive processes to extract intelligence from digitized images. The technology is context-based and identifies objects rather than simply examining individual pixels; enabling accurate analysis of complex images.
For more information visit www.definiens.com
JL Haber, Vice President of Programming at Multi Media Productions, added, “In our search for companies with innovative solutions that have the ability to change the way we live our lives, Definiens stood out as a unique company. We are excited to have them as a guest on our program.”
About 21st Century Health
21st Century Health airs on CNBC (as paid programming) and the Fox Business Network (as paid programming). 21st Century Health may also be viewed through video on demand via www.21chtv.com. The 21CHTV Series is also available at more than 90 prestigious college universities, including Carnegie Mellon University, Howard University, Dartmouth College and Georgetown University.
For specific market-by-market air dates and times, please e-mail Moniqueh@mmpusa.com. For more information, please visit www.21chtv.com.
Category: Pathology News